Yahoo Finance • 9 days ago

Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bausch Health Companies is one of them. Bausch Health Companies Inc. (NYSE:BHC), a global specialty pharmaceutical company, has recently gained attent... Full story

Yahoo Finance • 14 days ago

Bausch Health Completes $63 Mln Acquisition Of DURECT, Adds Breakthrough AH Therapy

(RTTNews) - Bausch Health Companies Inc. has successfully completed its tender offer to acquire DURECT Corporation (DRRX) for $1.75 per share in cash, totaling approximately $63 million upfront. The deal also includes up to $350 million i... Full story

Yahoo Finance • 27 days ago

Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition

We recently compiled a list of the 10 Overlooked Healthcare Stocks to Invest in. Bausch Health Companies Inc. is one of them. Bausch Health Companies Inc. (NYSE:BHC) is a global specialty pharmaceutical and medical device company focused... Full story

Yahoo Finance • 30 days ago

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) today announced that BHC Lyon Merger Sub... Full story

Yahoo Finance • last month

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of VBTX, CFSB, PVBC, and DRRX

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story

Yahoo Finance • 2 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of DURECT Corporation (NASDAQ: DRRX)

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 2 months ago

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitis Proposed acquisition... Full story

Yahoo Finance • 2 years ago

Q3 2023 DURECT Corp Earnings Call

Participants Tim Papp; CFO; DURECT Corporation Jim Brown; CEO; DURECT Corporation François Brisebois; Analyst; Oppenheimer & Co, Inc. Carl Byrnes; Analyst; Northland Capital Markets Thomas Yip; Analyst; H.C. Wainwright & Co., LLC Pre... Full story